SCHEMBL25311331

SCHEMBL25311331

O=C1OC(=CCCCN2CCN(c3ncc(C(F)(F)F)cn3)CC2)c2ccccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 6/20 0.47
TRPA1 O75762 1/20 0.40
DRD3 P35462 5/20 0.39
DRD2 P14416 4/20 0.39
HTR2A P28223 3/20 0.39
HTR7 P34969 3/20 0.39
HTR6 P50406 3/20 0.39
ABCB11 O95342 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.39
ADRA2A P08913 1/20 0.39
CYP2D6 P10635 1/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
DRD4 P21917 1/20 0.39
ADRA1D P25100 1/20 0.39
CYP2C19 P33261 1/20 0.39
ADRA1A P35348 1/20 0.39
ADRA1B P35368 1/20 0.39
DRD1 P21728 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25308826 0.82 SMN1; SMN2 (0.45) ALDH1A1CYP1A2CYP2D6CYP2C19
SCHEMBL30510783 0.82 SMN1; SMN2 (0.45) ALDH1A1CYP1A2CYP2D6CYP2C19
SCHEMBL25307357 0.78 SIGMAR1 (0.44) HTR1ADRD2CYP1A2
SCHEMBL25309387 0.73 TRPA1 (0.39) HTR1ATRPA1DRD3DRD2ALDH1A1
SCHEMBL30510789 0.73 TRPA1 (0.39) HTR1ATRPA1DRD3DRD2ALDH1A1
SCHEMBL25268518 0.70 DRD2 (0.53) HTR1ADRD3DRD2HTR2AHTR7
SCHEMBL25223898 0.69 SIGMAR1 (0.48) HTR1ADRD3DRD2HTR2ACYP1A2
SCHEMBL27233837 0.69 TIPARP (0.47) HTR1ADRD3DRD2HTR2AADRA2C
SCHEMBL25310691 0.69 TRPA1 (0.41) HTR1ATRPA1ALDH1A1DRD4
SCHEMBL30510832 0.69 TRPA1 (0.41) HTR1ATRPA1ALDH1A1DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023139536-A1 (4-PIPERAZIN-1YL)-4-ALKYL-PHTHALAZIN-1(2H)-ONE COMPOUNDS AS PARP7 INHIBITORS RHIZEN PHARMACEUTICALS AG (CH) 2023-07-27 WO disclosed